Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2024 Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2024 Earnings Call Transcript August 1, 2024

Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.18.

Operator: Good day and welcome to Lexicon Pharmaceuticals Second Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note...